ConductScience.org, home

Paper42686993

Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.

Nagler A and 22 others. Bone Marrow Transplant, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT. Papers, record 42686993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42686993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-03
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nagler AArnonhttps://orcid.org/0000-0002-0763-1265
2Swoboda RRyszardhttps://orcid.org/0000-0002-5897-3919
3Ferhat ATAllain Thibeault
4Blaise DDidierhttps://orcid.org/0000-0002-5684-9447
5Versluis JJurjenhttps://orcid.org/0000-0003-2372-1663
6Van Gorkom GGwendolynhttps://orcid.org/0000-0001-7327-7834
7Itala-Remes MMaija
8Colorado Araujo MMercedes
9Labussiere-Wallet HHelenehttps://orcid.org/0000-0003-0543-9592
10Yakoub-Agha IIbrahimhttps://orcid.org/0000-0003-4524-8782
11Peffault de Latour RRegis
12Gedde-Dahl TTobias
13Roeven MWHMieke W H
14Forcade EEdouardhttps://orcid.org/0000-0002-8873-2868
15Carré MMartin
16Chevallier PPatricehttps://orcid.org/0000-0003-3142-5581
17Desmier DDeborah
18Musso MMaurizio
19Sanz JJaimehttps://orcid.org/0000-0001-6934-4619
20Brissot EEoliahttps://orcid.org/0000-0003-4471-418X

Source PubMed

See all 23 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135605254Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission.Blood Adv2022https://conductscience.org/library/papers/35605254PubMed
236949658Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.Br J Haematol2023https://conductscience.org/library/papers/36949658PubMed
333030517Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.JAMA Oncol2020https://conductscience.org/library/papers/33030517PubMed
430078459Acute myeloid leukaemia.Lancet2018https://conductscience.org/library/papers/30078459PubMed
538581695
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer2024https://conductscience.org/library/papers/38581695PubMed
626010177Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.Am J Hematol2015https://conductscience.org/library/papers/26010177PubMed
720629023
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Cancer2010https://conductscience.org/library/papers/20629023PubMed
82143514Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.J Immunol1990https://conductscience.org/library/papers/2143514PubMed
933054609Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.Hematology2020https://conductscience.org/library/papers/33054609PubMed
1039439234Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia.Br J Haematol2024https://conductscience.org/library/papers/39439234PubMed
1140927841
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol2025https://conductscience.org/library/papers/40927841PubMed
1233148668Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia.Clin Cancer Res2021https://conductscience.org/library/papers/33148668PubMed
1340523209Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.J Clin Oncol2025https://conductscience.org/library/papers/40523209PubMed
1439018507Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.J Clin Oncol2024https://conductscience.org/library/papers/39018507PubMed
1538538862ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Leukemia2024https://conductscience.org/library/papers/38538862PubMed
1632375860Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.J Hematol Oncol2020https://conductscience.org/library/papers/32375860PubMed
1738374026
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood Cancer J2024https://conductscience.org/library/papers/38374026PubMed
1837342922Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.N Engl J Med2023https://conductscience.org/library/papers/37342922PubMed
1940305657Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.Blood Adv2025https://conductscience.org/library/papers/40305657PubMed
206996481Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Am J Med1980https://conductscience.org/library/papers/6996481PubMed

See all 27 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42686993

GET https://conductscience.org/api/papers/v1/42686993/authors?page=2